Initiation of phase II study of triple combination therapy for the treatment of chronic HBV March 1, 2021
IDMC recommends stopping enrollment of placebo group in phase III outpatient trial of REGEN-COV Feb. 26, 2021
Altimmune initiates enrollment in phase I study of AdCOVID intranasal COVID-19 vaccine candidate Feb. 26, 2021
Data from proof-of-concept OSCAR study of otilimab in hospitalized patients with COVID-19 Feb. 26, 2021
RSS